GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nectar Lifesciences Ltd (NSE:NECLIFE) » Definitions » Institutional Ownership

Nectar Lifesciences (NSE:NECLIFE) Institutional Ownership : 0.05% (As of Jun. 25, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Nectar Lifesciences Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nectar Lifesciences's institutional ownership is 0.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nectar Lifesciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nectar Lifesciences's Float Percentage Of Total Shares Outstanding is 0.00%.


Nectar Lifesciences Institutional Ownership Historical Data

The historical data trend for Nectar Lifesciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nectar Lifesciences Institutional Ownership Chart

Nectar Lifesciences Historical Data

The historical data trend for Nectar Lifesciences can be seen below:

2018-04-30 2018-05-31 2018-06-30 2018-07-31 2018-08-31 2018-09-30 2021-07-31 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.31 0.31 0.27 0.20 0.02 0.02 0.02 0.05 0.05 0.05

Nectar Lifesciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Nectar Lifesciences (NSE:NECLIFE) Business Description

Traded in Other Exchanges
Address
SCO 38-39, Sector 9d, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.

Nectar Lifesciences (NSE:NECLIFE) Headlines

No Headlines